0001694187-20-000014.txt : 20200227
0001694187-20-000014.hdr.sgml : 20200227
20200227182140
ACCESSION NUMBER: 0001694187-20-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200225
FILED AS OF DATE: 20200227
DATE AS OF CHANGE: 20200227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Al-Wakeel Yasir B.
CENTRAL INDEX KEY: 0001650691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38551
FILM NUMBER: 20664449
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001694187
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 110
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-337-4701
MAIL ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 110
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_158284568348788.xml
FORM 4
X0306
4
2020-02-25
0
0001694187
Neon Therapeutics, Inc.
NTGN
0001650691
Al-Wakeel Yasir B.
C/O NEON THERAPEUTICS, INC.
40 ERIE STREET, SUITE 110
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
Common Stock
2020-02-25
4
F
0
5385
1.51
D
201856
D
These shares represent shares withheld to satisfy tax obligations arising from the vesting of restricted stock units awarded to the reporting person on November 25, 2019 and do not represent a discretionary trade by the reporting person. The number of shares to be withheld was determinable on February 25, 2020.
/s/ Jolie M. Siegel, as attorney in fact
2020-02-27